Cancan Diagnostic is delighted to announce the launch of K9-LiquiDX, marking the advent of the first-ever Minimal Residual Disease (MRD) test engineered specifically for dogs. Set to be released on March 5, 2024, K9-LiquiDX embodies a significant stride in veterinary oncology, equipping vets and pet owners with an advanced tool for the early detection of cancer relapse and meticulous disease…